Faculty profile

Kasmintan Schrader

ResearcherGeneticsUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Kasmintan Schrader

Researcher

Genetics

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
2 publications in the last five years, latest in 2026.
Principal investigator on 6 research grants (6 CIHR), most recently in 2024.
Supervised 1 trainee who won CIHR awards, most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

127

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Hereditary Cancer Cancer Susceptibility Cell-Free Dna Gastrointestinal Cancer Incidental Findings Leukaemia Molecular Surveillance Multiple Primary Cancers

Latest papers

“Where do I go from here?” Navigating a lifelong road without a map: the care experiences of hereditary cancer patients
European Journal of Human Genetics · 2026
“Should I Let Them Know I Have This?”: Multifaceted Genetic Discrimination and Limited Awareness of Legal Protections among Individuals with Hereditary Cancer Syndromes
Public Health Genomics · 2024
Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes.
Nature cancer · 2020

All 11 publications

Latest funding

Enhanced Population Cancer Care through Mainstream Genome Sequencing and Parent-of-Origin Detection
CIHR · 2024 · Nominated PI
$2,000,000
Implementation of a clinical population screening program for BRCA1/2 mutations among individuals of Ashkenazi Jewish ancestry
CIHR · 2023 · Supervisor
$54,250
Parent-of-Origin-Aware Genomic Analysis in Hereditary Cancer
CIHR · 2023 · Nominated PI
$30,000

All 11 grants and awards

11 publications.

“Where do I go from here?” Navigating a lifelong road without a map: the care experiences of hereditary cancer patients

Butkowsky C, Carroll JC, Aronson M, Sam J, Reble E, Clausen M, Gopalakrishnan R, Sparkes B, Rajeziesfahani S, Aguda V

European Journal of Human Genetics20261 citations

DOI: 10.1038/s41431-026-02069-y

“Should I Let Them Know I Have This?”: Multifaceted Genetic Discrimination and Limited Awareness of Legal Protections among Individuals with Hereditary Cancer Syndromes

Gopalakrishnan R, Sam J, Butkowsky C, Reble E, Clausen M, Rajeziesfahani S, Sparkes B, Aguda V, Aronson M, Bishop D

Public Health Genomics20246 citations

DOI: 10.1159/000542210

Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes.

Pleasance E, Titmuss E, Williamson L, Kwan H, Culibrk L, Zhao EY, Dixon K, Fan K, Bowlby R, Jones MR, Shen Y, Grewal JK, Ashkani J, Wee K, Grisdale CJ, Thibodeau ML, Bozoky Z, Pearson H, Majounie E, Vira T, Shenwai R, Mungall KL, Chuah E, Davies A, Warren M, Reisle C, Bonakdar M, Taylor GA, Csizmok V, Chan SK, Zong Z, Bilobram S, Muhammadzadeh A, D'Souza D, Corbett RD, MacMillan D, Carreira M, Choo C, Bleile D, Sadeghi S, Zhang W, Wong T, Cheng D, Brown SD, Holt RA, Moore RA, Mungall AJ, Zhao Y, Nelson J, Fok A, Ma Y, Lee MKC, Lavoie JM, Mendis S, Karasinska JM, Deol B, Fisic A, Schaeffer DF, Yip S, Schrader K, Regier DA, Weymann D, Chia S, Gelmon K, Tinker A, Sun S, Lim H, Renouf DJ, Laskin J, Jones SJM, Marra MA

Nature cancer2020

DOI: 10.1038/s43018-020-0050-6 PMID: 35121966

Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial

Bombard Y, Clausen M, Shickh S, Mighton C, Casalino S, Kim THM, Muir SM, Carlsson L, Baxter N, Scheer A

Genetics in Medicine202058 citations

DOI: 10.1038/s41436-019-0702-z

Quality of life drives patients’ preferences for secondary findings from genomic sequencing

Mighton C, Carlsson L, Clausen M, Casalino S, Shickh S, McCuaig L, Joshi E, Panchal S, Semotiuk K, Ott K

European Journal of Human Genetics202030 citations

DOI: 10.1038/s41431-020-0640-x

Development of patient “profiles” to tailor counseling for incidental genomic sequencing results

Mighton C, Carlsson L, Clausen M, Casalino S, Shickh S, McCuaig L, Joshi E, Panchal S, Graham T, Aronson M

European Journal of Human Genetics201932 citations

DOI: 10.1038/s41431-019-0352-2

The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results.

Bombard Y, Clausen M, Mighton C, Carlsson L, Casalino S, Glogowski E, Schrader K, Evans M, Scheer A, Baxter N, Hamilton JG, Lerner-Ellis J, Offit K, Robson M, Laupacis A

European journal of human genetics : EJHG2018

DOI: 10.1038/s41431-018-0144-0 PMID: 29703952

Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing.

Wong HL, Yang KC, Shen Y, Zhao EY, Loree JM, Kennecke HF, Kalloger SE, Karasinska JM, Lim HJ, Mungall AJ, Feng X, Davies JM, Schrader K, Zhou C, Karsan A, Jones SJM, Laskin J, Marra MA, Schaeffer DF, Gorski SM, Renouf DJ

Cold Spring Harbor molecular case studies2018

DOI: 10.1101/mcs.a002329 PMID: 29092957

Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers.

Laskin J, Jones S, Aparicio S, Chia S, Ch'ng C, Deyell R, Eirew P, Fok A, Gelmon K, Ho C, Huntsman D, Jones M, Kasaian K, Karsan A, Leelakumari S, Li Y, Lim H, Ma Y, Mar C, Martin M, Moore R, Mungall A, Mungall K, Pleasance E, Rassekh SR, Renouf D, Shen Y, Schein J, Schrader K, Sun S, Tinker A, Zhao E, Yip S, Marra MA

Cold Spring Harbor molecular case studies2015

DOI: 10.1101/mcs.a000570 PMID: 27148575

Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia.

Topka S, Vijai J, Walsh MF, Jacobs L, Maria A, Villano D, Gaddam P, Wu G, McGee RB, Quinn E, Inaba H, Hartford C, Pui CH, Pappo A, Edmonson M, Zhang MY, Stepensky P, Steinherz P, Schrader K, Lincoln A, Bussel J, Lipkin SM, Goldgur Y, Harit M, Stadler ZK, Mullighan C, Weintraub M, Shimamura A, Zhang J, Downing JR, Nichols KE, Offit K

PLoS genetics2015

DOI: 10.1371/journal.pgen.1005262 PMID: 26102509

Enhanced Population Cancer Care through Mainstream Genome Sequencing and Parent-of-Origin Detection

Nominated PICIHR2024Operating Grant: CIHR-ICR / Genome Canada Partnership - Research Grants

Principal investigators: Schrader, Kasmintan A

Keywords: Cancer; Cancer Prevention; Genetic Counselling; Gentic Testing; Germline; Hereditary; Risk-Reduction

$2,000,000

Implementation of a clinical population screening program for BRCA1/2 mutations among individuals of Ashkenazi Jewish ancestry

SupervisorCIHR2023Health System Impact Fellowships - PostDoc Western Canada 2-year

Principal investigators: Shickh, Salma A

Keywords: Cancer Prevention; Genetic Diseases; Health Policy; Health Systems; Hereditary Cancer Syndromes; Knowledge Translation; Learning Health System; Population Screening; Public Health

$54,250

Parent-of-Origin-Aware Genomic Analysis in Hereditary Cancer

Nominated PICIHR2023PRIZE - Project Grant - PA: Maud Menten - Clinical Research

Principal investigators: Schrader, Kasmintan A

Keywords: Hereditary Cancer

$30,000

Gynecologic Cancer Impact Accelerator

Co-investigatorCIHR2023Planning and Dissemination Grant - Institute Community Support

Principal investigators: Mcalpine, Jessica N

Keywords: Cancer Care Delivery; Ethnicity; Genetic Testing; Gynecologic Cancer; Health Equity; Knowledge Mobilization; Molecular Classification; Precision Oncology; Prevention; Race

$10,000

Strengthening the Healthcare Workforce: Enhancing Genetic Counselling Access and Efficiency

Co-investigatorCIHR2023Team Gr.: Strength the Health Workforce for Sys. Transf.:Cancer Health Workforce

Principal investigators: Elliott, Alison M; Nuk, Jennifer; Lynd, Larry D

Keywords: Cancer; Genetic Counselling; Genetics; Newborn Screening; Pediatrics; Primary Care

$250,000

Parent-of-Origin-Aware Genomic Analysis in Hereditary Cancer

Nominated PICIHR2022Project Grant

Principal investigators: Schrader, Kasmintan A; Jones, Steven; Lansdorp, Peter M

Keywords: Cancer Susceptibility; Cascade Genetic Testing; Hereditary Cancer; Long Read Sequencing; Parent-Of-Origin; Strand-Seq; Whole Genome Sequencing

$852,974

Canada Research Chair - Tier 2

Nominated PICIHR2020Canada Research Chairs - CIHR Funded - Tier 2

Principal investigators: Schrader, Kasmintan A

Keywords: Crc

$600,000

Molecular detection of known and novel cancer predisposition genes

Nominated PICIHR2019CIHR Clinician Scientist - Phase 2

Principal investigators: Schrader, Kasmintan A

Keywords: Cancer Susceptibility; Cell-Free Dna; Gastrointestinal Cancer; Hereditary Cancer; Incidental Findings; Leukaemia; Molecular Surveillance; Multiple Primary Cancers; Next-Generation Sequencing; Pancreatic Cancer

$180,000

Preference analyses and development of an e-health app facilitating communication of test results for hereditary cancer syndromes

Co-investigatorCIHR2017Catalyst Grant: Personalized Health Catalyst Grants

Principal investigators: Regier, Dean A

Keywords: Discrete Choice Experiment; Hereditary Cancer Syndromes; Precision Medicine; Shared Decision Making

$200,000

Molecular detection of known and novel cancer predisposition genes

Nominated PICIHR2014CIHR Clinician Scientist - Phase 2

Principal investigators: Schrader, Kasmintan A

$300,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Kasmintan Schrader

Research

Latest papers

Latest funding

“Where do I go from here?” Navigating a lifelong road without a map: the care experiences of hereditary cancer patients

“Should I Let Them Know I Have This?”: Multifaceted Genetic Discrimination and Limited Awareness of Legal Protections among Individuals with Hereditary Cancer Syndromes

Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes.

Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial

Quality of life drives patients’ preferences for secondary findings from genomic sequencing

Development of patient “profiles” to tailor counseling for incidental genomic sequencing results

The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results.

Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing.

Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers.

Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia.

Frequent collaborators

Yvonne Bombard

Andrea Eisen

Andrea Eisen

Jordan Lerner-Ellis

Anna Tinker

Petros Pechlivanoglou

Holly Etchegary

Lesa Dawson

Aly Karsan

David Huntsman

Nancy Baxter

Andreas Laupacis

Sevtap Savas

Wei Zhang

Steven Jones

Samuel Aparicio

Kevin Thorpe